Vancouver, WA
Summary
This company specializes in biologics drug discovery, utilizing generative AI to create novel antibodies and biologics therapies. Their innovative approach allows for the design of antibodies from scratch, bypassing traditional methods that rely on existing libraries. By integrating AI with synthetic biology, they aim to streamline the drug creation process, reduce development timelines, and improve success rates in bringing new therapies to patients, particularly for challenging diseases.
8 of 8 checks passed
Label
Value
Active Dates
17.9 years — Since Feb 2007
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
541714
SIC 4 Digit Code
8731
SIC 2 Digit Code
87
Industry
1. Biotechnology and Pharmaceutical
2. Research and Development in Biotechnology (except Nanobiotechnology)
Vendor
Source
Microsoft
TXT Record
Atlassian
TXT Record
DocuSign
TXT Record
TXT Record
Smartsheet
TXT Record
ZenDesk
TXT Record
Mimecast
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2009 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2010 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2011 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2012 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|